NCT05442762 Social Media-based Vaccine Confidence and Hesitancy Monitoring Status WITHDRAWN Phase N/A
NCT05438420 Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05435209 Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents Status COMPLETED Phase PHASE4
NCT05429541 Pneumococcal Carriage and Serotype Distribution in Children With Otitis Media in Malaysia. Status UNKNOWN Phase N/A
NCT05425732 Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults (V116-003, STRIDE-3) Status COMPLETED Phase PHASE3
NCT05421806 A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/ Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05420961 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6) Status COMPLETED Phase PHASE3
NCT05420012 The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation Status COMPLETED Phase PHASE4
NCT05418790 A Pilot Study to Evaluate Alternative Viral Load Tests During Start of Antiretroviral Therapy Status UNKNOWN Phase NA
NCT05406713 Pembrolizumab in Muscle-invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05406440 A Study of Elpipodect (MK-8189) in Participants With Schizophrenia (MK-8189-014) Status COMPLETED Phase PHASE1
NCT05406401 A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05405595 ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05405465 Effectiveness of Golimumab in Patients With Ulcerative Colitis: Results of a Real-life Study in Switzerland Status COMPLETED Phase N/A
NCT05404945 Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05394350 A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002) Status TERMINATED Phase PHASE1/PHASE2
NCT05394103 Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05393037 Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7) Status COMPLETED Phase PHASE3
NCT05389527 Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2